CDNA analyst estimates
CareDx (CDNA) analyst ratings, the average price target and its range, and every firm's latest call.
CDNA analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 30, 2026 | Canaccord Genuity | CareDx, Inc (CDNA) PT Raised to $99 at Canaccord, 'We believe CDNA is positioned for solid revenue expansion over time' | $99.00 |
| Oct 30, 2026 | BTIG | CareDx, Inc (CDNA) PT Raised to $92 at BTIG | $92.00 |
| Oct 27, 2026 | BTIG | CareDx, Inc (CDNA) PT Raised to $81 at BTIG | $81.00 |
| Sep 24, 2026 | BTIG | CareDx, Inc (CDNA) PT Raised to $74 at BTIG | $74.00 |
| Sep 2, 2026 | Canaccord Genuity | CareDx initiated with a Buy at Canaccord | $65.00 |
| Aug 6, 2026 | BTIG | CareDx price target raised to $60 from $45 at BTIG | $60.00 |
| Aug 3, 2026 | Craig-Hallum | CareDx upgraded to Buy from Hold at Craig-Hallum | $64.00 |
| Jul 31, 2026 | H.C. Wainwright | H.C. Wainwright Reiterates Neutral Rating on CareDx, Inc (CDNA) | $46.00 |
| Jul 16, 2026 | Craig-Hallum | Craig-Hallum ups CareDx price target after 'quite favorable' Medicare LCD | $35.00 |
| Jul 16, 2026 | BTIG | CareDx price target raised to $45 from $28 at BTIG | $45.00 |
| Apr 29, 2026 | BTIG | CareDx price target raised to $28 from $26 at BTIG | $28.00 |
| Feb 25, 2026 | BTIG | CareDx, Inc (CDNA) PT Raised to $26 at BTIG | $26.00 |
| Jan 6, 2026 | Craig-Hallum | CareDx downgraded to Hold from Buy at Craig-Hallum | $26.00 |
| Dec 15, 2025 | Wells Fargo | CareDx price target raised to $18 from $14 at Wells Fargo | $18.00 |
| Mar 3, 2025 | H.C. Wainwright | CareDx price target lowered to $25 from $26 at H.C. Wainwright | $25.00 |
- 4 firms rate CDNA: 2 buy, 2 hold, 0 sell.
- The average price target is $75.25 from 4 analysts, from $46.00 to $99.00.
Updated 2026-11-02 17:13 UTC